Novel Coronavirus (COVID-19)
UMSOM Info |
Return to Campus Info
Thomas Scalea, MD, Has Pioneered Significant Advances in Trauma Care at Helm of the Premier R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center
Learn More about World-Renowned University of Maryland Medicine Trauma Surgeon and Physician-Scientist Celebrates 25th Anniversary
First-of-Its-Kind Transplant at the University of Maryland Medical Center Was Patient’s Only Option for Survival after Being Deemed Ineligible for Traditional Transplant
Learn More about University of Maryland School of Medicine Faculty Scientists and Clinicians Perform Historic First Successful Transplant of Porcine Heart into Adult Human with End-Stage Heart Disease
Research Shows Vaccine Has 90 Percent Efficacy at Preventing Infections; Moderate to Severe Disease Occurred Only in Placebo Recipients
Learn More about Novavax COVID-19 Vaccine Found to be Safe and Effective in Phase 3 Trial Conducted by UM School of Medicine Researchers
Recognized with Top Award for Outstanding COVID-19 Communications Program
Learn More about UM School of Medicine’s Office of Public Affairs and Communications Honored with 2021 PRSA ‘Best In Maryland’ Award
Variant Linked to Lower LDL Cholesterol Levels and Blood Clotting Protein; Could Lead to New Cardiovascular Treatments
Learn More about UM School of Medicine & Regeneron Researchers Link New Gene Variant in Amish Population to Lower Risk of Heart Disease
Research Will Expand Knowledge of Open Angle Glaucoma to Hopefully Lead to Earlier Treatment for a Leading Cause of Blindness
Learn More about UM School of Medicine Researchers Awarded $2 Million NIH Grant to Use Innovative Imaging to Study Causes of Glaucoma
Under a new race-neutral assessment, thousands of African American persons living with chronic kidney disease could gain access to specialty treatment or transplantation for the first time
Learn More about University of Maryland Medicine to Eliminate Race from Kidney Function Estimates
